Seebri Neohaler (glycopyrrolate) is an inhaler used to treat chronic obstructive pulmonary disease (COPD). Although it was FDA approved in 2015, it's no longer available in the United States because it was discontinued.
Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD)
Asthma in people age 6 years and older - Spiriva Respimat only
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Sunovion Pharmacueticals Inc. (2021). Seebri Neohaler- glycopyrrolate capsule [package insert]. DailyMed.
U.S. Food and Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs - Glycopyrrolate.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.